Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.

Geretti AM, White E, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C, Dunn DT; UK HIV Drug Resistance Database and UK CHIC Study .

J Antimicrob Chemother. 2019 Mar 1;74(3):746-753. doi: 10.1093/jac/dky468.

2.

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.

Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database; UK CHIC study.

AIDS. 2013 Sep 10;27(14):2245-53. doi: 10.1097/QAD.0b013e3283636179.

PMID:
24157905
3.

Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis.

Flight WG, Bright-Thomas RJ, Tilston P, Mutton KJ, Guiver M, Morris J, Webb AK, Jones AM.

Thorax. 2014 Mar;69(3):247-53. doi: 10.1136/thoraxjnl-2013-204000. Epub 2013 Oct 14.

PMID:
24127019
4.

Chronic rhinovirus infection in an adult with cystic fibrosis.

Flight WG, Bright-Thomas RJ, Tilston P, Mutton KJ, Guiver M, Webb AK, Jones AM.

J Clin Microbiol. 2013 Nov;51(11):3893-6. doi: 10.1128/JCM.01604-13. Epub 2013 Aug 21.

5.

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors.

Koning FA, Castro H, Dunn D, Tilston P, Cane PA, Mbisa JL; UK Collaborative Group on HIV Drug Resistance.

J Antimicrob Chemother. 2013 Jun;68(6):1220-36. doi: 10.1093/jac/dkt012. Epub 2013 Feb 5.

PMID:
23386260
6.

The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the United Kingdom.

Green H, Tilston P, Fearnhill E, Pillay D, Dunn DT; UK Collaborative Group on HIV Drug Resistance.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):196-204. doi: 10.1097/QAI.0b013e318185725f.

PMID:
18769348
7.

Genotypic antiretroviral drug resistance testing at low viral loads in the UK.

Cane PA, Kaye S, Smit E, Tilston P, Kirk S, Shepherd J, Hopkins M, Zhang H, Geretti AM.

HIV Med. 2008 Oct;9(8):673-6. doi: 10.1111/j.1468-1293.2008.00607.x. Epub 2008 Jun 28.

8.

Pilot scheme for performance assessment of HIV-1 genotypic resistance testing in the UK.

Cane PA, Aitkin C, Ward K, Clarke J, Parmar S, Zuckerman M, Smith M, Tilston P, O'Shea S, Pillay D.

Commun Dis Public Health. 2004 Mar;7(1):24-9.

PMID:
15137277
9.

A study of anal intraepithelial neoplasia in HIV positive homosexual men.

Lacey HB, Wilson GE, Tilston P, Wilkins EG, Bailey AS, Corbitt G, Green PM.

Sex Transm Infect. 1999 Jun;75(3):172-7.

10.

Anal human papillomavirus and anal cancer.

Tilston P.

J Clin Pathol. 1997 Aug;50(8):625-34. Review. No abstract available.

11.

A single tube nested PCR for the detection of hepatitis C virus RNA.

Tilston P, Corbitt G.

J Virol Methods. 1995 May;53(1):121-9.

PMID:
7635921
12.

Commercial assay for hepatitis C virus RNA.

Tilston P, Morris DJ, Klapper PE, Corbitt G.

Lancet. 1994 Jul 16;344(8916):201-2. No abstract available.

PMID:
7912802
13.

Supplemental Content

Loading ...
Support Center